Boston, MA, September 15, 2020 -- WorldCare Clinical (WCC), a leading provider of imaging services in Oncology clinical trials, today announced that it had commenced radiology, dermatology, and oncology central…
Boston, MA, June 15, 2020 -- WorldCare Clinical (WCC) a leading provider of imaging and endpoint assessment committeesfor hepatic clinical trials, today announced that it had commenced MRI and DXA(dual-energy…
May 21, 2020 - Boston, MA WorldCare Clinical (WCC), a leading CRO focused on maximizing the precision and accuracy of independent endpoint assessments in clinical trials, today announced that its…
DUBLIN, Ohio--(BUSINESS WIRE)-- Navidea Biopharmaceuticals,Inc. (NYSE American: NAVB) ("Navidea" or the "Company"), a company focused onthe development of precision immunodiagnostic agents and immunotherapeutics,today announced that it has signed a letter…
Boston, MA, December 6, 2019 - WorldCare Clinical (WCC), a leading CRO focused on maximizingthe precision and accuracy of imaging assessments, announced its advanced quantitativecardiac echo images services. For over25…
Boston, MA, April 19, 2019 -- WorldCare Clinical (WCC), a leading provider of imaging services for clinical trials in hematological and oncological diseases, today announced how its technology system and…
Boston, MA, March 12, 2019 -- WorldCare Clinical (WCC), aleading CRO focused on maximizing the precision and accuracy of independent endpoint assessments in clinical trials, today announced its integrated pathology…
Barcelona, Spain, November 15, 2018 -- WCC will be exhibiting at the Partnerships in Clinical Trials Europe conference and featuring its imaging core lab and endpoint adjudication services November 27-29,…
King of Prussia, PA, May 21, 2018 -- WorldCare Clinical, a leading provider of imaging services for clinical trials, will be at the show and featuring its imaging core lab…
Burlingame, CA, February 21, 2018 -- WorldCare Clinical, a leading provider of imaging services for clinical trials, will be exhibiting at the show and featuring its imaging core lab…
Vice President, Quality Assurance and Regulatory Affairs
Vice President, Program Management
Chief Scientific Officer
Dr. Walovitch is Chief Scientific Officer of WCC, which he joined as Chief Medical Officer in January 2009. Prior to joining WCC, he served as the Senior Vice President of clinical research at Acusphere, Inc., Vice President of Preclinical and Clinical Research at Epix Medical, and held various positions as Research Pharmacologist and Project Clinician in the Imaging Agent Group at the DuPont Merck Pharmaceutical Company. He completed his postdoctoral fellowship at the National Institute on Drug Abuse’s Addiction Research Center in the Neurochemistry section. Dr. Walovitch has a Doctorate in Pharmacology from the University of Illinois Medical Center and a Bachelor’s degree in biology from the University of Illinois. He is an author of more than 100 peer-reviewed publications, mostly in the field of medical imaging.
Chief Executive Officer